Skip to main content

Ambulatory Heart Rate Variability Correlates with High-Sensitivity C - Reactive Protein in Type 2 Diabetes and Control Subjects

  • Conference paper
  • First Online:
  • 1463 Accesses

Part of the book series: IFMBE Proceedings ((IFMBE,volume 59))

Abstract

Type 2 diabetes mellitus has been associated with elevated high-sensitivity C-reactive protein (hsCRP), but the possible implication of ambulatory heart rate (HR) variability in enhancing chronic subclinical inflammation biomarkers remains to be elucidated. We aimed to evaluate the correlations between HR variability and coefficient of variance assessed during 24-hour ambulatory blood pressure monitoring (ABPM) and hsCRP in type 2 diabetes and control subjects. The observational study included type 2 diabetes (n=75) and control (n=11) subjects. HR variability was calculated as standard deviation of mean HR during daytime, nighttime and 24-hour periods. The coefficient of variation was calculated using standard deviation and mean HR. Nighttime HR dipping was calculated using daytime and nighttime HR variability. We found higher hsCRP in type 2 diabetes compared to controls. Also, we found that daytime, nighttime and 24-hour HR variability and coefficient of variance were lower in the type 2 diabetes group compared with the control group, while type 2 diabetes subjects receiving β-blockers had even lower ambulatory HR variability and coefficient of variance. Subjects with diabetic neuropathy, retinopathy and atherosclerotic cardiovascular disease had lower HR variability and coefficient of variance compared to their peers without disease. We observed that daytime and 24-hour HR variability inversely correlated with hsCRP, while all HR variability parameters inversely correlated with hypertension duration in the study population. Nighttime HR dipping inversely correlated with duration of type 2 diabetes and hypertension. Our results suggest that 24-hour ambulatory HR variability and coefficient of variance are significantly correlated with chronic inflammation evaluated using hsCRP in type 2 diabetes and control subjects, and these findings deserve further investigations.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. França da Silva AK, Penachini da Costa de Rezende Barbosa M, Marques Vanderlei F et al. (2016) Application of Heart Rate Variability in Diagnosis and Prognosis of Individuals with Diabetes Mellitus: Systematic Review. Ann Noninvasive Electrocardiol 21(3):223-235 DOI:10.1111/anec.12372

  2. Sucharita S, Bantwal G, Idiculla J et al. (2011) Autonomic nervous system function in type 2 diabetes using conventional clinical autonomic tests, heart rate and blood pressure variability measures. Indian J Endocrinol Metab 15(3):198-203 DOI:10.4103/2230-8210.83406

  3. Ziegler D, Zentai CP, Perz S et al. (2008) Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 31(3):556-561 DOI:10.2337/dc07-1615

  4. Yamaguchi Y, Wada M, Sato H et al. (2015) Impact of nocturnal heart rate variability on cerebral small-vessel disease progression: a longitudinal study in community-dwelling elderly Japanese. Hypertens Res 38(8):564-569 DOI:10.1038/hr.2015.38

  5. Sloan RP, McCreath H, Tracey KJ et al. (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007 13(3-4):178-184 DOI:10.2119/2006–00112.Sloan

  6. Frasure-Smith N, Lespérance F, Irwin MR et al. (2009) The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun 23(8):1140-1147 DOI:10.1016/j.bbi.2009.07.005

  7. Aso Y, Wakabayashi S, Nakano T et al. (2006) High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Metabolism 55(8):1014-1021 DOI:10.1016/j.metabol.2006.03.011

  8. Ciobanu DM, Bala CG, Veresiu IA et al. (2016) High-sensitivity C-reactive protein is associated with 24-hour ambulatory blood pressure variability in type 2 diabetes and control subjects. Rev Rom Med Lab 24(1):65-73 DOI:10.1515/rrlm-2016-0013

  9. American Diabetes Association. (2015) 2. Classification and Diagnosis of Diabetes. Diabetes Care 39(Suppl 1):S13-S22 DOI:10.2337/dc15-S005

  10. Mancia G, Fagard R, Narkiewicz K et al. (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159-2219 DOI:10.1093/eurheartj/eht151

  11. van den Berg MP, Haaksma J, Brouwer J et al. (1997) Heart rate variability in patients with atrial fibrillation is related to vagal tone. Circulation 96(4):1209-1216 DOI:10.1161/01.cir.96.4.1209

  12. Vinik AI, Maser RE, Mitchell BD, Freeman R. (2003) Diabetic autonomic neuropathy. Diabetes Care 26(5):1553-1579 DOI:10.2337/diacare.26.5.1553

  13. Lanza GA, Pitocco D, Navarese EP et al. (2007) Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J 28(7):814-820 DOI:10.1093/eurheartj/ehm018

  14. Jenkins NP, Keevil BG, Hutchinson IV, Brooks NH. (2002) Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 112(4):269-74 DOI: 10.1016/S0002-9343(01)01115-9

  15. Shannon J, Jordan J, Costa F et al. (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062-1067 DOI: 10.1161/01.HYP.30.5.1062

  16. Eguchi K, Pickering TG, Hoshide S et al. (2008) Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 21(4):443-450 DOI:10.1038/ajh.2008.4

  17. Ciobanu DM, Veresiu IA, Bala CG et al. (2015) Benefits of bedtime hypertension medication in type 2 diabetes demonstrated on ambulatory blood pressure monitoring. Proceedings of the 49th Annual Scientific Meeting of the European Society for Clinical Investigation. Medimond, Bologna, Italy, pp 107-112

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. M. Ciobanu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this paper

Cite this paper

Ciobanu, D.M., Crăciun, A.E., Vereşiu, I.A., Bala, C., Roman, G. (2017). Ambulatory Heart Rate Variability Correlates with High-Sensitivity C - Reactive Protein in Type 2 Diabetes and Control Subjects. In: Vlad, S., Roman, N. (eds) International Conference on Advancements of Medicine and Health Care through Technology; 12th - 15th October 2016, Cluj-Napoca, Romania. IFMBE Proceedings, vol 59. Springer, Cham. https://doi.org/10.1007/978-3-319-52875-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52875-5_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52874-8

  • Online ISBN: 978-3-319-52875-5

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics